Lali, Ricky
Chong, Michael
Omidi, Arghavan
Mohammadi-Shemirani, Pedrum http://orcid.org/0000-0001-6740-7858
Le, Ann
Cui, Edward
Paré, Guillaume http://orcid.org/0000-0002-6795-4760
Article History
Received: 6 February 2020
Accepted: 6 September 2021
First Online: 6 October 2021
Competing interests
: M.C. has received consulting fees from Bayer. G.P. has received consulting fees from Bayer, Sanofi, Amgen, and Illumina. The remaining authors declare no competing interests.